Bisoprolol hair loss is best handled with timeline logic, because most medication-linked shedding behaves like telogen effluvium (TE): the trigger happens first, and shedding becomes noticeable later. Importantly, the FDA label for ZEBETA (bisoprolol) lists alopecia within the Skin adverse-experience list reported in worldwide studies or postmarketing experience. This does not prove causation for an individual person—but it confirms a real signal worth considering when timing and pattern fit.
Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change bisoprolol without clinician guidance. If you’re not sure whether you’re seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapid worsening, start here: When to See a Doctor.
Quick navigation
- Key takeaways (fast)
- What the FDA label says (and what it doesn’t)
- Timeline: onset, peak, recovery (TE logic)
- Pattern clues: TE vs AGA vs AA vs breakage
- When labs matter (targeted workup)
- What to do (practical plan)
- When to see a doctor
- References
Key takeaways (fast)
- FDA label signal: ZEBETA (bisoprolol) lists alopecia in the Skin adverse-experience list reported in worldwide studies/postmarketing experience.
- TE timing is delayed: DermNet notes increased hair fall is often noticed 2–4 months after a trigger; BAD notes it can occur around ~3 months after a trigger.
- Pattern matters: medication-linked TE is typically diffuse and non-scarring; persistent part/crown widening after shedding slows suggests TE + AGA overlap.
- Related on this site: Beta-Blocker Hair Loss (Overview) • Atenolol Hair Loss • Metoprolol Hair Loss • Propranolol Hair Loss • Medication-Related Shedding.
What the FDA label says (and what it doesn’t)
What it says: the ZEBETA label lists alopecia under Skin among adverse experiences reported in worldwide studies or postmarketing experience.
What it does not say: it doesn’t provide a clean “true incidence” you can apply to everyone. Clinically, the most reliable interpretation tool remains pattern + timing.
Timeline: onset, peak, recovery (TE logic)
- Onset: TE is delayed—hair fall is often noticed weeks-to-months after the trigger. DermNet describes a common delay of 2–4 months; BAD commonly cites around ~3 months.
- Peak: shedding often feels worst for several weeks once it starts.
- Recovery: once triggers stabilize (often via clinician-guided medication strategy + fixing overlap contributors), shedding slows first; density recovery takes longer.
Pattern clues: TE vs AGA vs AA vs breakage
- Most consistent with TE: diffuse shedding + normal scalp + delayed timing after starting/changing bisoprolol.
- TE + AGA overlap: if shedding slows but part/crown keeps widening: TE vs Androgenetic Alopecia.
- Patchy smooth bald spots: consider alopecia areata: Alopecia Areata Hub.
- Lots of short snapped hairs: consider breakage: Hair Breakage (Hair-Shaft).
When labs matter (targeted workup)
If shedding is heavy, persistent, recurrent, or symptoms suggest overlap causes, clinicians often screen for common contributors (iron status, thyroid function, etc.). Use:
What to do (practical plan)
- Build a timeline: start date, dose changes, and the month shedding became noticeable.
- Confirm the pattern: TE vs breakage vs overlap AGA vs AA.
- Talk to the prescriber: if timing fits, discuss options (watchful waiting vs dose adjustment vs switching) based on cardiovascular risk/benefit. Do not self-stop.
- Avoid supplement roulette: supplement only if there’s a deficiency signal (labs/clinical context).
- Track monthly: photos every 4 weeks (same angle/light).
When to see a doctor
- Scalp pain/burning, pustules, open sores, heavy scale/crusting
- Patchy smooth bald spots
- Shedding persisting beyond ~6 months or recurrent waves
Start here: When to See a Doctor.
References (trusted sources)
- FDA label: ZEBETA (bisoprolol) — includes alopecia under Skin
- DermNet NZ: Telogen effluvium (timing often 2–4 months after trigger)
- British Association of Dermatologists: Telogen effluvium (~3 months after a trigger)
Last updated: March 09, 2026.
